WHO

January 2013: Proposal for the inclusion of trastuzumab in WHO EML for treatment of HER2-Positive Breast Cancer

Posted on by Thiru

On 14 January 2013, Knowledge Ecology International (KEI), the University of California (San Francisco), Universities Allied for Essential Medicines (UAEM), Third World Network (TWN) and Young Professionals Chronic Disease Network: YP-CDN submitted a Proposal for the Inclusion of Trastuzumab in the WHO Model List of Essential Medicines for the Treatment of HER2-Positive Breast Cancer to WHO’s Exper Continue Reading →

67th WHA Side Event on Innovation and Access for Middle-Income Countries, Wednesday 21 May 2014

Posted on by Claire Cassedy

This Wednesday 21 May 2014, Knowledge Ecology International (KEI), Civil Society Coalition, Medecins Sans Frontieres (MSF), Oxfam, Health Action International (HAI) and Treatment Action Group (TAG) will host a side event at the WHA on, “Innovation and Access to Medicines and Vaccines: Emerging Challenges and Opportunities for Middle-Income Countries.”

Continue Reading →

Call for Action on Cancer Drugs by YP-CDN, KEI, and UAEM at 67th World Health Assembly

Posted on by Claire Cassedy

At the opening of the 67th World Health Assembly, today the Young Professionals Chronic Disease Network (YP-CDN), Knowledge Ecology International (KEI), and Universities Allied for Essential Medicines (UAEM) released a briefing, “Cancer medicines are essential in reducing the global burden of non-communicable diseases.”

Continue Reading →

KEI proposal for Antibiotics Innovation Funding Mechanism (AIFM), shortlisted for demonstration project by WHO’s EURO region

Posted on by James Love

The WHO is considering potential projects that will demonstrate the feasibility and benefits of open innovation models, delinkage of R&D costs and product prices, and innovative finance mechanisms. The process for selection began at the regional level, as each of six WHO regions was allowed to shortlist four projects that will be considered at a December 3-4, 2013 meeting of experts in Geneva, where the list will be narrowed again, and then considered by the WHO Executive Board in January 2014 and the WHO World Health Assembly in May 2014. Continue Reading →

Approval, ownership, market structure, and placement on WHO EML for 100 new cancer NMEs on NCI alpha list

Posted on by James Love

KEI research associate Paul Miano has written the following paper: Cancer: Approval, ownership, market structure, and placement on WHO Model Essential Medicines List, for 100 new molecular entities (NMEs) on the NCI alpha list of cancer drugs and vaccines. KEI Research Note 2011:1,

A full copy of the paper is available in PDF format here.

The following is from the introduction (sans footnotes, which are in the PDF version):

Introduction and Summary

Continue Reading →

1

The baffling WHO EWG analysis of innovation inducement prizes

Posted on by James Love

The World Health Organization (WHO) Executive Board will soon consider the Executive Summary of the Report of the Expert Working Group on Research and Development Financing, a document, formally identified as EB 126/6 Add.1.

In the section of the report on “Funding allocation proposals,” the EWG considers two types of innovation inducement prizes, including

31 (c) milestone prizes; and
31 (d) end-prizes (cash)

Continue Reading →

Colombian Submission to the WHO IGWG negotiation favors drug company positions on IP

Posted on by Judit Rius

By resolution WHA 59.24, the WHO’s Intergovernmental Working Group on Public Health, Innovation, and Intellectual Property (IGWG) has the goal of producing a Global Strategy and Plan of Action that will implement the CIPIH report recommendations and “secure an enhanced and sustainable basis for needs-driven, essential health research and development relevant to diseases that disproportionately affect developing countries, proposing cle Continue Reading →

2005: Letter of 162 experts asking World Health Organization to evaluate a proposed treaty framework for medical research and development.

Posted on by James Love

The attached is a February 24, 2005 letter signed by 162 experts, asking the World Health Organization to Evaluate New Treaty Framework for Medical Research and Development The proposal for a Medical R&D Treaty (MRDT) was designed as an alternative… Continue Reading →